Chemical Compound

(2S)-1-[2-[(3-Hydroxytricyclo[3.3.1.13,7]dec-1-yl)amino]acetyl]-2-pyrrolidinecarbonitrile; 2-Pyrrolidinecarbonitrile, 1-[[(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)amino]acetyl]-, (2S)- (9CI); (S)-1-[2-[(3-Hydroxyadamant-1-yl)amino]acetyl]pyrrolidine-2-carbonitrile; DSP 7238; Equa; Galvus; LAF 237; NVP-LAF 237; Vildagliptin

CAS Registry Number 274901-16-5
返回搜索 申请报价
(2S)-1-[2-[(3-Hydroxytricyclo[3.3.1.13,7]dec-1-yl)amino]acetyl]-2-pyrrolidinecarbonitrile; 2-Pyrrolidinecarbonitrile, 1-[[(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)amino]acetyl]-, (2S)- (9CI); (S)-1-[2-[(3-Hydroxyadamant-1-yl)amino]acetyl]pyrrolidine-2-carbonitrile; DSP 7238; Equa; Galvus; LAF 237; NVP-LAF 237; Vildagliptin 结构式
Primary record

(2S)-1-[2-[(3-Hydroxytricyclo[3.3.1.13,7]dec-1-yl)amino]acetyl]-2-pyrrolidinecarbonitrile; 2-Pyrrolidinecarbonitrile, 1-[[(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)amino]acetyl]-, (2S)- (9CI); (S)-1-[2-[(3-Hydroxyadamant-1-yl)amino]acetyl]pyrrolidine-2-carbonitrile; DSP 7238; Equa; Galvus; LAF 237; NVP-LAF 237; Vildagliptin

库存
3,856 克
纯度
98.4 %
CAS
274901-16-5

化合物标识与属性

CAS
274901-16-5
PubChem CID
6918537
SMILES
C1C[C@H](N(C1)C(=O)CNC23CC4CC(C2)CC(C4)(C3)O)C#N
Canonical SMILES
N#C[C@@H]1CCCN1C(=O)CNC12CC3CC(CC(O)(C3)C1)C2

名称与同义词

  • Vildagliptin
  • Galvus
  • Xiliarx
  • Jalra
  • Equa
  • 274901-16-5
  • Vitagliptin
  • vildagliptine
  • NVP-LAF237
  • Vildagliptina
  • vildagliptinum
  • Zomelis
  • Galvu
  • LAF237
  • vildagliptin HCl
  • Zomelis;
  • Galvus;
  • Galvus (TN)
  • Vildagliptin (LAF-237)
  • LAF-237
  • Vildagliptin [USAN]
  • NVP-LAF 237
  • NVP-LAF-237
  • LAF 237
  • Equa (TN)
  • RefChem:6349
  • AC1OCFK2
  • Vildagliptin hydrochloride
  • Vidagliptin (see Vildagliptin)
  • I6B4B2U96P
  • NVP LAF237
  • UNII-I6B4B2U96P
  • VILDAGLIPTIN [MI]
  • VILDAGLIPTIN [INN]
  • VILDAGLIPTIN [JAN]
  • D0L3DK
  • CHEMBL142703
  • Vildagliptin (JAN/USAN/INN)
  • SCHEMBL16579
  • VILDAGLIPTIN [MART.]
  • VILDAGLIPTIN [WHO-DD]
  • GTPL6310
  • PYR288
  • VILDAGLIPTIN [EMA EPAR]
  • Vildagliptin (NVP-LAF 237)
  • BDBM11695
  • Vildagliptin - Bio-X trade mark
  • Vildagliptin [USAN:INN:BAN:JAN]
  • A10BD08
  • A10BH02
  • DTXSID80881091
  • CHEBI:135285
  • MFCD08275142
  • SYOKIDBDQMKNDQ-XWTIBIIYSA-N
  • C17H25N3O2
  • DTXCID501508682
  • MSK11066
  • NP3358
  • s3033
  • (2S)-1-[2-[(3-hydroxy-1-adamantyl)amino]acetyl]pyrrolidine-2-carbonitrile
  • AKOS015898120
  • C17-H25-N3-O2
  • AC-1273
  • ACN-034463
  • CCG-267505
  • CID6918537
  • CS-1465
  • DB04876
  • FV29102
  • CID:6918537
  • KS-0000024W
  • NCGC00386200-01
  • NCGC00386200-02
  • BC657793
  • BR-49179
  • BV164521
  • HY-14291
  • SC-20831
  • SID:376229685
  • AB1008531
  • AM20090695
  • NS00010516
  • SW220049-1
  • D07080
  • S-4169
  • AB01566863_01
  • 2-Pyrrolidinecarbonitrile, 1-[2-[(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)amino]acetyl]-, (2S)-
  • A819091
  • C502012
  • EN300-18527744
  • Q421042
  • (2S)-1-{2-[(3-hydroxyadamantan-1-yl)amino]acetyl}pyrrolidine-2-carbonitrile
  • Vildagliptin, 97%, DPP-4 inhibitor - 10MG 10mg
  • (2S)-(((3-hydroxyadamantan-1-yl)amino)acetyl)pyrrolidine-2-carbonitrile
  • BRD-A94993966-001-04-4
  • BRD-A94993966-001-05-1
  • D000077597
  • 1-[[(3-Hydroxy-1-adamantyl)amino]acetyl]-2-cyano-(S)-pyrrolidine
  • 1-[2-[(3-hydroxy-1-adamantyl)amino]acetyl]pyrrolidine-2-carbonitrile
  • (S)-1-[2-[(3-Hydroxyadamant-1-yl)amino]acetyl]pyrrolidine-2-carbonitrile
  • (2S)-1-((3-hydroxyadamantan-1-yl)glycyl)pyrrolidine-2-carbonitrile
  • (S)-1-(2-(((1r,3R,5R,7S)-3-hydroxyadamantan-1-yl)amino)acetyl)pyrrolidine-2-carbonitrile
  • (S)-1-[N-(3-hydroxy-1-adamantyl)glycyl]pyrrolidine-2-carbonitrile
  • (2S)-{((3-Hydroxyadamantan-1-yl)amino)acetyl}pyrrolidine-2-carbonitrile
  • (2S)-1-(2-((3-hydroxy-1-adamantyl)amino)acetyl)pyrrolidine-2-carbonitrile
  • (2S)-1-[N-(3-Hydroxyadamantan-1-yl)glycyl]pyrrolidine-2-carbonitrile
  • (2S)-1-{[(3-hydroxyadamant-1-yl)amino]acetyl}pyrrolidine-2-carbonitrile
  • (2S)-1-{2-[(3-Hydroxyadamant-1-yl)amino]acetyl}pyrrolidine-2-carbonitrile
  • 2-Pyrrolidinecarbonitrile, 1-(((3-hydroxytricyclo(3.3.1.13,7)dec-1-yl)amino)acetyl)-, (2S)-
  • (2S)-1-{[(3-Hydroxytricyclo[3.3.1.13,7]dec-1-yl)amino]acetyl}pyrrolidine-2-carbonitrile
  • 1-[2-[(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)amino]acetyl]-2S-pyrrolidinecarbonitrile
  • (-)-(2S)-1-(((3-HYDROXYTRICYCLO(3.3.1.1(SUP(3,7))DEC-1-YL)AMINO)ACETYL)PYRROLIDINE-2-CARBONITRILE
  • (-)-(2S)-1-[[(3-Hydroxytricyclo[3.3.1.1[3,7]]dec-1-yl)amino]acetyl]pyrrolidine-2-carbonitrile
  • (2S)-1-(((3-HYDROXYTRICYCLO(3.3.1.1(SUP 3,7))DEC-1-YL)AMINO)ACETYL)PYRROLIDINE-2-CARBONITRILE
  • (2S)-1-[2-[(3-Hydroxy-tricyclo[3.3.1.13,7 ]dec-1-yl)amino]acetyl]-2-pyrrolidinecarbonitrile
  • (2S)-1-[2-[(3-Hydroxytricyclo[3.3.1.13,7]dec-1-yl)amino]acetyl]- 2-pyrrolidinecarbonitrile
  • (2S)-1-[2-[(3-Hydroxytricyclo[3.3.1.13,7]dec-1-yl)amino]acetyl]-2-pyrrolidinecarbonitrile; 2-Pyrrolidinecarbonitrile, 1-[[(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)amino]acetyl]-, (2S)- (9CI); (S)-1-[2-[(3-Hydroxyadamant-1-yl)amino]acetyl]pyrrolidine-2-carbonitrile; DSP 7238; Equa; Galvus; LAF 237; NVP-LAF 237; Vildagliptin
  • 2-PYRROLIDINECARBONITRILE, 1-(((3-HYDROXYTRICYCLO(3.3.1.1(SUP 3,7))DEC-1-YL)AMINO)ACETYL)-, (2S)-
  • 2-Pyrrolidinecarbonitrile, 1-[[(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)amino]acetyl]-, (2S)-(9CI)
  • 2-Pyrrolidinecarbonitrile,1-[2-[(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)amino]acetyl]-,(2S)-
  • 2S)-1-[[(3-Hydroxytricyclo[3.3.1.13,7]decane-1-yl)amino]acetyl]-2-pyrrolidinecarbonitrile